The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02523495

Enrollment

120

Registered

2015-08-14

Start date

2012-06-30

Completion date

2022-07-31

Last updated

2018-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms, Therapy-Associated

Keywords

Molecular Targeted Therapy, metastasis colorectal cancer, biomarker

Brief summary

Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer and explore some biomarkers that relate to target therapy.

Detailed description

1. Establish a clinical database of patients who are diagnosed with metastasis colorectal cancer in tongji hospital. 2. Build a biological specimen banks of metastasis colorectal cancer through collecting blood samples from those patients who have reached an agreement with us. 3. Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer. 4. To extract DNA from the blood and explore some biomarkers that related to target therapy in metastasis colorectal cancer.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Metastasis colorectal cancer confirmed by histologically and radiography 2. Receive target therapy over half a year 3. Have a measurable lesions

Exclusion criteria

1\. A history of other malignant tumors in five years

Design outcomes

Primary

Measure	Time frame
overall survival	5 years

Countries

China

Contacts

Primary ContactYuan Xianglin, Professional

yxl@medmail.com.cn13667241722

Backup ContactZhao Ben, Master

zhaoben0609@163.com15071206621

Outcome results